Like all living things, the human body requires a constant and regular supply of oxygen, but the mechanisms for absorption and distribution in the body are very fragile and susceptible to problems; they become worse along with increasing age and with a variety of illnesses. This is where SanguiBioTech GmbH comes in:

The study and development of drugs and medicinal products to provide assistance when the supply of oxygen to the body’s tissues and cells is disrupted form the core competence of SanguiBioTech GmbH.

These products are based on decades of research and development carried out by Prof. Dr. Dr. W. Barnikol and Dr. Harald Pötzschke and their staff at the Universities of Mainz and Witten/Herdecke as well as in the company’s laboratories. Significant findings are extensively protected by a variety of international patents – these patents and processes and the related expertise represent the scientific capital of SanguiBioTech GmbH.

(Most problematic chronic wounds (venous and foot ulcers) are likely due to a deficiency of oxygen, which are in turn caused by a diagnosable underlying disease – particularly by venous insufficiency (varicose veins and complications following deep vein thrombosis), arterial circulatory disorders (intermittent claudication and “smoker’s leg”) or diabetes mellitus.
A product helpful in the healing of wounds is a spray with hemoglobin (Granulox° hemoglobin spray), which transports oxygen from the air to the damaged tissue, thus mitigating the oxygen deficiency. This medicinal product is produced and sold by our subsidiary, SastoMed GmbH (based in Georgsmarienhütte).)